ARTICLE | Clinical News
RQ-00000004: Phase I started
July 14, 2014 7:00 AM UTC
RaQualia began a Japanese Phase I trial of RQ-00000004. The product is in Phase II testing for GERD in Korea. CJ Group’s CJ CheilJedang Co. affiliate has exclusive rights to develop and commercialize ...